| |
| |
|
| Insider
Information: |
Rhodes Jennifer J |
| Relationship: |
See Remarks |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
104,603 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$549,196 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
104,603 |
|
|
| Total
Value |
$549,196 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -159.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Medivation Inc |
MDVN |
GC & Corporate Secretary |
2015-03-16 |
11,090 |
|
0 |
Premium* |
|
|
Adamas Pharmaceuticals Inc |
ADMS |
CBO, GC & Compliance O... |
2019-06-20 |
63,114 |
2016-05-06 |
0 |
Premium* |
|
|
Elicio Therapeutics Ord Shs |
ELTX |
See Remarks |
2021-12-14 |
30,399 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ELTX |
Elicio Therapeutics Ord S... |
See Remarks |
• – – |
2021-12-14 |
4 |
AS |
$2.42 |
$1,090 |
D/D |
(451) |
30,399 |
0 |
% |
|
| ELTX |
Elicio Therapeutics Ord S... |
See Remarks |
• – – |
2021-11-15 |
4 |
AS |
$4.40 |
$1,905 |
D/D |
(433) |
30,850 |
0 |
% |
|
| ELTX |
Elicio Therapeutics Ord S... |
See Remarks |
• – – |
2021-10-14 |
4 |
AS |
$8.65 |
$3,720 |
D/D |
(430) |
31,283 |
0 |
% |
|
| ELTX |
Elicio Therapeutics Ord S... |
See Remarks |
• – – |
2021-09-14 |
4 |
AS |
$10.64 |
$4,575 |
D/D |
(430) |
31,713 |
0 |
% |
|
| ELTX |
Elicio Therapeutics Ord S... |
See Remarks |
• – – |
2021-08-16 |
4 |
AS |
$10.68 |
$4,753 |
D/D |
(445) |
32,143 |
0 |
% |
|
| ELTX |
Elicio Therapeutics Ord S... |
See Remarks |
• – – |
2021-07-21 |
4 |
AS |
$10.94 |
$4,726 |
D/D |
(432) |
32,588 |
0 |
% |
|
| ELTX |
Elicio Therapeutics Ord S... |
See Remarks |
• – – |
2021-07-14 |
4 |
AS |
$11.01 |
$4,745 |
D/D |
(431) |
32,589 |
0 |
% |
|
| ELTX |
Elicio Therapeutics Ord S... |
See Remarks |
• – – |
2021-05-14 |
4 |
AS |
$13.92 |
$6,125 |
D/D |
(440) |
33,447 |
0 |
% |
|
| ELTX |
Elicio Therapeutics Ord S... |
See Remarks |
• – – |
2021-04-15 |
4 |
AS |
$15.01 |
$5,989 |
D/D |
(399) |
33,887 |
0 |
% |
|
| ELTX |
Elicio Therapeutics Ord S... |
See Remarks |
• – – |
2021-03-13 |
4 |
S |
$20.45 |
$10,205 |
D/D |
(499) |
34,286 |
0 |
% |
|
| ELTX |
Elicio Therapeutics Ord S... |
See Remarks |
• – – |
2021-02-13 |
4 |
S |
$19.54 |
$8,930 |
D/D |
(457) |
34,785 |
0 |
% |
|
| ELTX |
Elicio Therapeutics Ord S... |
See RemarksOfficer |
• – – |
2021-02-04 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
35,242 |
|
- |
|
| ELTX |
Elicio Therapeutics Ord S... |
See RemarksOfficer |
• – – |
2021-02-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
38,895 |
|
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
CBO, GC & Compliance Officer |
• – – |
2019-06-20 |
4 |
S |
$5.35 |
$5,029 |
D/D |
(940) |
63,114 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
CBO, GC & Compliance Officer |
• – – |
2019-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
61,612 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
CBO, GC & Compliance Officer |
• – – |
2019-03-20 |
4 |
S |
$7.99 |
$14,318 |
D/D |
(1,792) |
31,612 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
CBO, GC & Compliance Officer |
• – – |
2018-12-20 |
4 |
S |
$7.52 |
$3,196 |
D/D |
(425) |
33,404 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
CBO, GC & Compliance Officer |
• – – |
2018-06-21 |
4 |
S |
$25.48 |
$25,531 |
D/D |
(1,002) |
33,794 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
CBO, GC & Compliance Officer |
• – – |
2018-03-21 |
4 |
S |
$25.89 |
$25,424 |
D/D |
(982) |
34,128 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
CBO, GC & Compliance Officer |
• – – |
2018-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
35,110 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
CBO, GC & Compliance Officer |
• – – |
2017-12-21 |
4 |
S |
$32.30 |
$14,212 |
D/D |
(440) |
28,860 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
CBO, GC & Compliance Officer |
• – – |
2017-06-21 |
4 |
S |
$17.53 |
$18,254 |
D/D |
(1,041) |
28,455 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
CBO, GC & Compliance Officer |
• – – |
2017-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
11,250 |
27,187 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
General Counsel |
• – – |
2016-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,687 |
15,937 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
General Counsel |
• – – |
2016-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
11,250 |
11,250 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
